Ryan Gierke

Ryan Gierke

United States

Publications
  • Research
    Simplified Pneumococcal Vaccination Schedules for Adults Age 50 and Over Lead to Worse Health
    Author(s): Charles Stoecker, Lindsay Kim, Ryan Gierke and Tamara Pilishvili Charles Stoecker, Lindsay Kim, Ryan Gierke and Tamara Pilishvili

    Background: In 2014 the Advisory Committee on Immunization Practices (ACIP) approved a dose of 13-valent pneumococcal conjugate vaccine (PCV13) for all adults at age 65 years. This further complicated the pneumococcal vaccination schedule, which was already one of the most complicated schedules. Objective: This study documents simplified schedules that were considered and discarded by the pneumococcal working group before making the most recent recommendation. We examined the marginal cost-effectiveness of several simplified schedules for older adults (age 50+ years) when compared with current recommendations. Our primary outcome was the cost-effectiveness ratio of quality-adjusted life years to cost. Methods: We used a probabilistic model following a cohort of 50 year-olds with separate vaccination coverage and disease .. View More»
    DOI: 10.4172/2157-7560.1000373

    Abstract PDF